老年合并症直肠癌短程放疗后MRI缓解率:回顾性队列研究
该回顾性队列研究纳入47例直肠癌患者(中位年龄80岁),评估短程放疗后长间隔MRI缓解率。33例再分期MRI中73%达中度或良好缓解(mrTRG≤3),完全影像缓解12%,完全病理缓解5%。短程放疗可作为老年合并症患者替代放化疗的选择。
要点
- 短程放疗后长间隔再分期MRI显示73%患者达中度或良好缓解(mrTRG≤3)。
- 完全影像缓解(mrTRG 1)占12%,完全病理缓解占5%。
- 短程放疗后延迟手术组R0切除率90%,术后1年总生存率82%。
核心结论
- 短程放疗后长间隔至再分期可使73%的老年合并症直肠癌患者达中度或良好MRI缓解,可作为放化疗的替代选择。
研究设计与样本
- 回顾性队列研究,纳入2011至2017年一家大型教学医院接受短程放疗后行再分期MRI、延迟手术或未手术的直肠癌患者(cT1-4cN0-2 cM0-1),排除短程放疗与再分期MRI之间接受化疗者。
主要发现
- 共纳入47例患者(男:女=27:20),中位年龄80岁(范围53-88岁)。
- 33例患者在短程放疗后10周行MRI评估缓解,24例(73%)达mrTRG≤3。
- 基线MRI cT3或cT4期占85%(28例),短程放疗后ypT3或ypT4期仅20例(61%),差异有统计学意义(p < 0.01)。
- 完全影像缓解(mrTRG 1)4例(12%);临床N+期短程放疗前23例(70%),治疗后8例(30%),差异有统计学意义(p = 0.03)。
- 短程放疗后39例接受延迟手术(开始短程放疗后中位14周),35例(90%)达完整切缘切除;术后1年总生存率82%;完全病理缓解2例(5%)。
临床怎么用
- 对需降期的老年合并症直肠癌患者,可考虑短程放疗后长间隔再分期MRI评估缓解,作为放化疗的替代方案。
局限性
- 回顾性设计,样本量较小(47例),仅33例有再分期MRI缓解数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of the present study was to evaluate MRI response rate and clinical outcome of short-course radiotherapy (SCRT) on rectal cancer as an alternative to chemoradiotherapy in patients where downstaging is indicated. METHODS: A retrospective analysis was performed of a patient cohort with rectal carcinoma (cT1-4cN0-2 cM0-1) from a large teaching hospital receiving restaging MRI, deferred surgery or no surgery after SCRT between 2011 and 2017. Patients who received chemotherapy during the interval between SCRT and restaging MRI were excluded. The primary outcome measure was the magnetic resonance tumor regression grade (mrTRG) at restaging MRI after SCRT followed by a long interval. Secondary, pathological tumor stage, complete resection rate and 1-year overall survival were assessed. RESULTS: A total of 47 patients (M:F = 27:20, median age 80 (range 53-88) years), were included. In 33 patients MRI was performed for response assessment 10 weeks after SCRT. A moderate or good response (mrTRG≤3) was observed in 24 of 33 patients (73%). While most patients (85%; n = 28) showed cT3 or cT4 stage on baseline MRI, a ypT3 or ypT4 stage was found in only 20 patients (61%) after SCRT (p < 0.01). A complete radiologic response (mrTRG 1) was seen in 4 patients (12%). Clinical N+ stage was diagnosed in n = 23 (70%) before SCRT compared to n = 8 (30%) post-treatment (p = 0.03). After SCRT, 39 patients underwent deferred surgery (after a median of 14 weeks after start of SCRT) and a resection with complete margins was achieved in 35 (90%) patients. One-year overall survival after surgery was 82%. Complete pathological response was found in 2 patients (5%). CONCLUSIONS: The use of SCRT followed by a long interval to restaging showed a moderate to good response in 73% and therefore can be considered as an alternative to chemoradiotherapy in elderly comorbid patients.
引用
- Koëter T, van Elderen SGC, van Tilborg GFAJB, et al. MRI response rate after short-course radiotherapy on rectal cancer in the elderly comorbid patient: results from a retrospective cohort study. Radiat Oncol. 2020. PMID: 32122381. doi:10.1186/s13014-020-01500-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。